Review



synthetic ptdins 4 5 p2 complexes  (Echelon Biosciences)


Bioz Verified Symbol Echelon Biosciences is a verified supplier
Bioz Manufacturer Symbol Echelon Biosciences manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 85

    Structured Review

    Echelon Biosciences synthetic ptdins 4 5 p2 complexes
    Synthetic Ptdins 4 5 P2 Complexes, supplied by Echelon Biosciences, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synthetic ptdins 4 5 p2 complexes/product/Echelon Biosciences
    Average 85 stars, based on 1 article reviews
    synthetic ptdins 4 5 p2 complexes - by Bioz Stars, 2025-03
    85/100 stars

    Images



    Similar Products

    94
    Avanti Polar synthetic ptdins
    Synthetic Ptdins, supplied by Avanti Polar, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synthetic ptdins/product/Avanti Polar
    Average 94 stars, based on 1 article reviews
    synthetic ptdins - by Bioz Stars, 2025-03
    94/100 stars
      Buy from Supplier

    85
    Echelon Biosciences synthetic ptdins 4 5 p2 complexes
    Synthetic Ptdins 4 5 P2 Complexes, supplied by Echelon Biosciences, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synthetic ptdins 4 5 p2 complexes/product/Echelon Biosciences
    Average 85 stars, based on 1 article reviews
    synthetic ptdins 4 5 p2 complexes - by Bioz Stars, 2025-03
    85/100 stars
      Buy from Supplier

    86
    Echelon Biosciences synthetic phosphoinositides
    (A) Binding of tTG to recycling endosomes. The amounts of purified 125 I-tTG bound at 4°C to recycling endosomes immunoisolated from NIH3T3 cells lacking tTG were determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (B) The role of <t>phosphoinositides</t> in the tTG interaction with recycling endosomes. Binding of 50 nM purified tTG to recycling endosomes was tested in the presence of 100 µM free phosphoinositides. Bound tTG and endosomal Rab11A/Rab11B and transferrin receptor (TfR) were detected by immuno-blotting. The relative amounts of vesicle-bound tTG were quantified and compared to that in the sample without phosphoinositides in four independent experiments. Bars depict means ± SEM, *p<0.05. (C) The putative phospholipid-binding sequence and site within the fourth domain of tTG. (D) Comparative analysis of tTG binding to phosphoinositides. 125 I-tTG binding to synthetic liposomes (PolyPIPosomes™) containing indicated phiosphoinositides was determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (E) Association of tTG with phosphoinositides in cells. tTG was immunoprecipitated from extracts of WI-38 fibroblasts and the immune complexes were probed by immunoblotting for PI(3)P or PI(4)P. (F) The phospholipid-binding site in tTG is required for membrane targeting and externalization of the protein. K598A,K600A,R601A,K602A mutations (m-plbs) were generated within the phospholipid-binding site of tTG. NIH3T3 fibroblasts transfected with wild type tTG (wt) or its mutant deficient in phosphoinositide binding (m-plbs) were left untreated or treated with 10 mM neomycin for 24 h before induction of these proteins for 4 h. The contents of wt and m-plbs tTG in the recycling endosomes and cytosol were defined by immunoblotting ( left panels ). Cell surface and total levels of wt and m-plbs tTG were defined by surface biotinylation, isolation of surface protein fractions, and immunoblotting ( right panels ). The relative contents of wt and m-plbs tTG in the recycling endosomes and on the cell surface were quantified and compared to those for untreated cells expressing wt protein. Shown are representative of three independent experiments. Bars depict means ± SEM, **p<0.005. See also . (G) A proposed mechanism of unconventional tTG secretion. The de novo synthesized intracellular (cytoplasmic) tTG ( hexagons ) does not follow the classical, ER/Golgi-dependent secretion pathway, but is exported via a four-step unconventional secretion process mediated by recycling endosomes ( dotted arrows ). Solid arrows mark the major intracellular recycling route through the PNRC utilized by β1 integrins. See further comments in the text.
    Synthetic Phosphoinositides, supplied by Echelon Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synthetic phosphoinositides/product/Echelon Biosciences
    Average 86 stars, based on 1 article reviews
    synthetic phosphoinositides - by Bioz Stars, 2025-03
    86/100 stars
      Buy from Supplier

    86
    Cascadian Therapeutics synthetic ptdins 3 kinase inhibitor
    (A) Binding of tTG to recycling endosomes. The amounts of purified 125 I-tTG bound at 4°C to recycling endosomes immunoisolated from NIH3T3 cells lacking tTG were determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (B) The role of <t>phosphoinositides</t> in the tTG interaction with recycling endosomes. Binding of 50 nM purified tTG to recycling endosomes was tested in the presence of 100 µM free phosphoinositides. Bound tTG and endosomal Rab11A/Rab11B and transferrin receptor (TfR) were detected by immuno-blotting. The relative amounts of vesicle-bound tTG were quantified and compared to that in the sample without phosphoinositides in four independent experiments. Bars depict means ± SEM, *p<0.05. (C) The putative phospholipid-binding sequence and site within the fourth domain of tTG. (D) Comparative analysis of tTG binding to phosphoinositides. 125 I-tTG binding to synthetic liposomes (PolyPIPosomes™) containing indicated phiosphoinositides was determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (E) Association of tTG with phosphoinositides in cells. tTG was immunoprecipitated from extracts of WI-38 fibroblasts and the immune complexes were probed by immunoblotting for PI(3)P or PI(4)P. (F) The phospholipid-binding site in tTG is required for membrane targeting and externalization of the protein. K598A,K600A,R601A,K602A mutations (m-plbs) were generated within the phospholipid-binding site of tTG. NIH3T3 fibroblasts transfected with wild type tTG (wt) or its mutant deficient in phosphoinositide binding (m-plbs) were left untreated or treated with 10 mM neomycin for 24 h before induction of these proteins for 4 h. The contents of wt and m-plbs tTG in the recycling endosomes and cytosol were defined by immunoblotting ( left panels ). Cell surface and total levels of wt and m-plbs tTG were defined by surface biotinylation, isolation of surface protein fractions, and immunoblotting ( right panels ). The relative contents of wt and m-plbs tTG in the recycling endosomes and on the cell surface were quantified and compared to those for untreated cells expressing wt protein. Shown are representative of three independent experiments. Bars depict means ± SEM, **p<0.005. See also . (G) A proposed mechanism of unconventional tTG secretion. The de novo synthesized intracellular (cytoplasmic) tTG ( hexagons ) does not follow the classical, ER/Golgi-dependent secretion pathway, but is exported via a four-step unconventional secretion process mediated by recycling endosomes ( dotted arrows ). Solid arrows mark the major intracellular recycling route through the PNRC utilized by β1 integrins. See further comments in the text.
    Synthetic Ptdins 3 Kinase Inhibitor, supplied by Cascadian Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synthetic ptdins 3 kinase inhibitor/product/Cascadian Therapeutics
    Average 86 stars, based on 1 article reviews
    synthetic ptdins 3 kinase inhibitor - by Bioz Stars, 2025-03
    86/100 stars
      Buy from Supplier

    86
    Echelon Biosciences synthetic short chain octanoyl phosphoinositides
    (A) Binding of tTG to recycling endosomes. The amounts of purified 125 I-tTG bound at 4°C to recycling endosomes immunoisolated from NIH3T3 cells lacking tTG were determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (B) The role of <t>phosphoinositides</t> in the tTG interaction with recycling endosomes. Binding of 50 nM purified tTG to recycling endosomes was tested in the presence of 100 µM free phosphoinositides. Bound tTG and endosomal Rab11A/Rab11B and transferrin receptor (TfR) were detected by immuno-blotting. The relative amounts of vesicle-bound tTG were quantified and compared to that in the sample without phosphoinositides in four independent experiments. Bars depict means ± SEM, *p<0.05. (C) The putative phospholipid-binding sequence and site within the fourth domain of tTG. (D) Comparative analysis of tTG binding to phosphoinositides. 125 I-tTG binding to synthetic liposomes (PolyPIPosomes™) containing indicated phiosphoinositides was determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (E) Association of tTG with phosphoinositides in cells. tTG was immunoprecipitated from extracts of WI-38 fibroblasts and the immune complexes were probed by immunoblotting for PI(3)P or PI(4)P. (F) The phospholipid-binding site in tTG is required for membrane targeting and externalization of the protein. K598A,K600A,R601A,K602A mutations (m-plbs) were generated within the phospholipid-binding site of tTG. NIH3T3 fibroblasts transfected with wild type tTG (wt) or its mutant deficient in phosphoinositide binding (m-plbs) were left untreated or treated with 10 mM neomycin for 24 h before induction of these proteins for 4 h. The contents of wt and m-plbs tTG in the recycling endosomes and cytosol were defined by immunoblotting ( left panels ). Cell surface and total levels of wt and m-plbs tTG were defined by surface biotinylation, isolation of surface protein fractions, and immunoblotting ( right panels ). The relative contents of wt and m-plbs tTG in the recycling endosomes and on the cell surface were quantified and compared to those for untreated cells expressing wt protein. Shown are representative of three independent experiments. Bars depict means ± SEM, **p<0.005. See also . (G) A proposed mechanism of unconventional tTG secretion. The de novo synthesized intracellular (cytoplasmic) tTG ( hexagons ) does not follow the classical, ER/Golgi-dependent secretion pathway, but is exported via a four-step unconventional secretion process mediated by recycling endosomes ( dotted arrows ). Solid arrows mark the major intracellular recycling route through the PNRC utilized by β1 integrins. See further comments in the text.
    Synthetic Short Chain Octanoyl Phosphoinositides, supplied by Echelon Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synthetic short chain octanoyl phosphoinositides/product/Echelon Biosciences
    Average 86 stars, based on 1 article reviews
    synthetic short chain octanoyl phosphoinositides - by Bioz Stars, 2025-03
    86/100 stars
      Buy from Supplier

    86
    Echelon Biosciences synthetic phosphoinositides dic16
    (A) Binding of tTG to recycling endosomes. The amounts of purified 125 I-tTG bound at 4°C to recycling endosomes immunoisolated from NIH3T3 cells lacking tTG were determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (B) The role of <t>phosphoinositides</t> in the tTG interaction with recycling endosomes. Binding of 50 nM purified tTG to recycling endosomes was tested in the presence of 100 µM free phosphoinositides. Bound tTG and endosomal Rab11A/Rab11B and transferrin receptor (TfR) were detected by immuno-blotting. The relative amounts of vesicle-bound tTG were quantified and compared to that in the sample without phosphoinositides in four independent experiments. Bars depict means ± SEM, *p<0.05. (C) The putative phospholipid-binding sequence and site within the fourth domain of tTG. (D) Comparative analysis of tTG binding to phosphoinositides. 125 I-tTG binding to synthetic liposomes (PolyPIPosomes™) containing indicated phiosphoinositides was determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (E) Association of tTG with phosphoinositides in cells. tTG was immunoprecipitated from extracts of WI-38 fibroblasts and the immune complexes were probed by immunoblotting for PI(3)P or PI(4)P. (F) The phospholipid-binding site in tTG is required for membrane targeting and externalization of the protein. K598A,K600A,R601A,K602A mutations (m-plbs) were generated within the phospholipid-binding site of tTG. NIH3T3 fibroblasts transfected with wild type tTG (wt) or its mutant deficient in phosphoinositide binding (m-plbs) were left untreated or treated with 10 mM neomycin for 24 h before induction of these proteins for 4 h. The contents of wt and m-plbs tTG in the recycling endosomes and cytosol were defined by immunoblotting ( left panels ). Cell surface and total levels of wt and m-plbs tTG were defined by surface biotinylation, isolation of surface protein fractions, and immunoblotting ( right panels ). The relative contents of wt and m-plbs tTG in the recycling endosomes and on the cell surface were quantified and compared to those for untreated cells expressing wt protein. Shown are representative of three independent experiments. Bars depict means ± SEM, **p<0.005. See also . (G) A proposed mechanism of unconventional tTG secretion. The de novo synthesized intracellular (cytoplasmic) tTG ( hexagons ) does not follow the classical, ER/Golgi-dependent secretion pathway, but is exported via a four-step unconventional secretion process mediated by recycling endosomes ( dotted arrows ). Solid arrows mark the major intracellular recycling route through the PNRC utilized by β1 integrins. See further comments in the text.
    Synthetic Phosphoinositides Dic16, supplied by Echelon Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synthetic phosphoinositides dic16/product/Echelon Biosciences
    Average 86 stars, based on 1 article reviews
    synthetic phosphoinositides dic16 - by Bioz Stars, 2025-03
    86/100 stars
      Buy from Supplier

    86
    Nichiyu Giken Kogyo Co Ltd synthetic dipalmitoylated phosphoinositides cellsignals
    (A) Binding of tTG to recycling endosomes. The amounts of purified 125 I-tTG bound at 4°C to recycling endosomes immunoisolated from NIH3T3 cells lacking tTG were determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (B) The role of <t>phosphoinositides</t> in the tTG interaction with recycling endosomes. Binding of 50 nM purified tTG to recycling endosomes was tested in the presence of 100 µM free phosphoinositides. Bound tTG and endosomal Rab11A/Rab11B and transferrin receptor (TfR) were detected by immuno-blotting. The relative amounts of vesicle-bound tTG were quantified and compared to that in the sample without phosphoinositides in four independent experiments. Bars depict means ± SEM, *p<0.05. (C) The putative phospholipid-binding sequence and site within the fourth domain of tTG. (D) Comparative analysis of tTG binding to phosphoinositides. 125 I-tTG binding to synthetic liposomes (PolyPIPosomes™) containing indicated phiosphoinositides was determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (E) Association of tTG with phosphoinositides in cells. tTG was immunoprecipitated from extracts of WI-38 fibroblasts and the immune complexes were probed by immunoblotting for PI(3)P or PI(4)P. (F) The phospholipid-binding site in tTG is required for membrane targeting and externalization of the protein. K598A,K600A,R601A,K602A mutations (m-plbs) were generated within the phospholipid-binding site of tTG. NIH3T3 fibroblasts transfected with wild type tTG (wt) or its mutant deficient in phosphoinositide binding (m-plbs) were left untreated or treated with 10 mM neomycin for 24 h before induction of these proteins for 4 h. The contents of wt and m-plbs tTG in the recycling endosomes and cytosol were defined by immunoblotting ( left panels ). Cell surface and total levels of wt and m-plbs tTG were defined by surface biotinylation, isolation of surface protein fractions, and immunoblotting ( right panels ). The relative contents of wt and m-plbs tTG in the recycling endosomes and on the cell surface were quantified and compared to those for untreated cells expressing wt protein. Shown are representative of three independent experiments. Bars depict means ± SEM, **p<0.005. See also . (G) A proposed mechanism of unconventional tTG secretion. The de novo synthesized intracellular (cytoplasmic) tTG ( hexagons ) does not follow the classical, ER/Golgi-dependent secretion pathway, but is exported via a four-step unconventional secretion process mediated by recycling endosomes ( dotted arrows ). Solid arrows mark the major intracellular recycling route through the PNRC utilized by β1 integrins. See further comments in the text.
    Synthetic Dipalmitoylated Phosphoinositides Cellsignals, supplied by Nichiyu Giken Kogyo Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synthetic dipalmitoylated phosphoinositides cellsignals/product/Nichiyu Giken Kogyo Co Ltd
    Average 86 stars, based on 1 article reviews
    synthetic dipalmitoylated phosphoinositides cellsignals - by Bioz Stars, 2025-03
    86/100 stars
      Buy from Supplier

    86
    Millipore synthetic dipalmitoylated phosphoinositides cellsignals
    (A) Binding of tTG to recycling endosomes. The amounts of purified 125 I-tTG bound at 4°C to recycling endosomes immunoisolated from NIH3T3 cells lacking tTG were determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (B) The role of <t>phosphoinositides</t> in the tTG interaction with recycling endosomes. Binding of 50 nM purified tTG to recycling endosomes was tested in the presence of 100 µM free phosphoinositides. Bound tTG and endosomal Rab11A/Rab11B and transferrin receptor (TfR) were detected by immuno-blotting. The relative amounts of vesicle-bound tTG were quantified and compared to that in the sample without phosphoinositides in four independent experiments. Bars depict means ± SEM, *p<0.05. (C) The putative phospholipid-binding sequence and site within the fourth domain of tTG. (D) Comparative analysis of tTG binding to phosphoinositides. 125 I-tTG binding to synthetic liposomes (PolyPIPosomes™) containing indicated phiosphoinositides was determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (E) Association of tTG with phosphoinositides in cells. tTG was immunoprecipitated from extracts of WI-38 fibroblasts and the immune complexes were probed by immunoblotting for PI(3)P or PI(4)P. (F) The phospholipid-binding site in tTG is required for membrane targeting and externalization of the protein. K598A,K600A,R601A,K602A mutations (m-plbs) were generated within the phospholipid-binding site of tTG. NIH3T3 fibroblasts transfected with wild type tTG (wt) or its mutant deficient in phosphoinositide binding (m-plbs) were left untreated or treated with 10 mM neomycin for 24 h before induction of these proteins for 4 h. The contents of wt and m-plbs tTG in the recycling endosomes and cytosol were defined by immunoblotting ( left panels ). Cell surface and total levels of wt and m-plbs tTG were defined by surface biotinylation, isolation of surface protein fractions, and immunoblotting ( right panels ). The relative contents of wt and m-plbs tTG in the recycling endosomes and on the cell surface were quantified and compared to those for untreated cells expressing wt protein. Shown are representative of three independent experiments. Bars depict means ± SEM, **p<0.005. See also . (G) A proposed mechanism of unconventional tTG secretion. The de novo synthesized intracellular (cytoplasmic) tTG ( hexagons ) does not follow the classical, ER/Golgi-dependent secretion pathway, but is exported via a four-step unconventional secretion process mediated by recycling endosomes ( dotted arrows ). Solid arrows mark the major intracellular recycling route through the PNRC utilized by β1 integrins. See further comments in the text.
    Synthetic Dipalmitoylated Phosphoinositides Cellsignals, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synthetic dipalmitoylated phosphoinositides cellsignals/product/Millipore
    Average 86 stars, based on 1 article reviews
    synthetic dipalmitoylated phosphoinositides cellsignals - by Bioz Stars, 2025-03
    86/100 stars
      Buy from Supplier

    Image Search Results


    (A) Binding of tTG to recycling endosomes. The amounts of purified 125 I-tTG bound at 4°C to recycling endosomes immunoisolated from NIH3T3 cells lacking tTG were determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (B) The role of phosphoinositides in the tTG interaction with recycling endosomes. Binding of 50 nM purified tTG to recycling endosomes was tested in the presence of 100 µM free phosphoinositides. Bound tTG and endosomal Rab11A/Rab11B and transferrin receptor (TfR) were detected by immuno-blotting. The relative amounts of vesicle-bound tTG were quantified and compared to that in the sample without phosphoinositides in four independent experiments. Bars depict means ± SEM, *p<0.05. (C) The putative phospholipid-binding sequence and site within the fourth domain of tTG. (D) Comparative analysis of tTG binding to phosphoinositides. 125 I-tTG binding to synthetic liposomes (PolyPIPosomes™) containing indicated phiosphoinositides was determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (E) Association of tTG with phosphoinositides in cells. tTG was immunoprecipitated from extracts of WI-38 fibroblasts and the immune complexes were probed by immunoblotting for PI(3)P or PI(4)P. (F) The phospholipid-binding site in tTG is required for membrane targeting and externalization of the protein. K598A,K600A,R601A,K602A mutations (m-plbs) were generated within the phospholipid-binding site of tTG. NIH3T3 fibroblasts transfected with wild type tTG (wt) or its mutant deficient in phosphoinositide binding (m-plbs) were left untreated or treated with 10 mM neomycin for 24 h before induction of these proteins for 4 h. The contents of wt and m-plbs tTG in the recycling endosomes and cytosol were defined by immunoblotting ( left panels ). Cell surface and total levels of wt and m-plbs tTG were defined by surface biotinylation, isolation of surface protein fractions, and immunoblotting ( right panels ). The relative contents of wt and m-plbs tTG in the recycling endosomes and on the cell surface were quantified and compared to those for untreated cells expressing wt protein. Shown are representative of three independent experiments. Bars depict means ± SEM, **p<0.005. See also . (G) A proposed mechanism of unconventional tTG secretion. The de novo synthesized intracellular (cytoplasmic) tTG ( hexagons ) does not follow the classical, ER/Golgi-dependent secretion pathway, but is exported via a four-step unconventional secretion process mediated by recycling endosomes ( dotted arrows ). Solid arrows mark the major intracellular recycling route through the PNRC utilized by β1 integrins. See further comments in the text.

    Journal: PLoS ONE

    Article Title: Unconventional Secretion of Tissue Transglutaminase Involves Phospholipid-Dependent Delivery into Recycling Endosomes

    doi: 10.1371/journal.pone.0019414

    Figure Lengend Snippet: (A) Binding of tTG to recycling endosomes. The amounts of purified 125 I-tTG bound at 4°C to recycling endosomes immunoisolated from NIH3T3 cells lacking tTG were determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (B) The role of phosphoinositides in the tTG interaction with recycling endosomes. Binding of 50 nM purified tTG to recycling endosomes was tested in the presence of 100 µM free phosphoinositides. Bound tTG and endosomal Rab11A/Rab11B and transferrin receptor (TfR) were detected by immuno-blotting. The relative amounts of vesicle-bound tTG were quantified and compared to that in the sample without phosphoinositides in four independent experiments. Bars depict means ± SEM, *p<0.05. (C) The putative phospholipid-binding sequence and site within the fourth domain of tTG. (D) Comparative analysis of tTG binding to phosphoinositides. 125 I-tTG binding to synthetic liposomes (PolyPIPosomes™) containing indicated phiosphoinositides was determined in a gamma counter with all measurements performed in triplicates. Shown are means ± SEM for three independent experiments. (E) Association of tTG with phosphoinositides in cells. tTG was immunoprecipitated from extracts of WI-38 fibroblasts and the immune complexes were probed by immunoblotting for PI(3)P or PI(4)P. (F) The phospholipid-binding site in tTG is required for membrane targeting and externalization of the protein. K598A,K600A,R601A,K602A mutations (m-plbs) were generated within the phospholipid-binding site of tTG. NIH3T3 fibroblasts transfected with wild type tTG (wt) or its mutant deficient in phosphoinositide binding (m-plbs) were left untreated or treated with 10 mM neomycin for 24 h before induction of these proteins for 4 h. The contents of wt and m-plbs tTG in the recycling endosomes and cytosol were defined by immunoblotting ( left panels ). Cell surface and total levels of wt and m-plbs tTG were defined by surface biotinylation, isolation of surface protein fractions, and immunoblotting ( right panels ). The relative contents of wt and m-plbs tTG in the recycling endosomes and on the cell surface were quantified and compared to those for untreated cells expressing wt protein. Shown are representative of three independent experiments. Bars depict means ± SEM, **p<0.005. See also . (G) A proposed mechanism of unconventional tTG secretion. The de novo synthesized intracellular (cytoplasmic) tTG ( hexagons ) does not follow the classical, ER/Golgi-dependent secretion pathway, but is exported via a four-step unconventional secretion process mediated by recycling endosomes ( dotted arrows ). Solid arrows mark the major intracellular recycling route through the PNRC utilized by β1 integrins. See further comments in the text.

    Article Snippet: Membrane lipid strips (#P6002); PIP strips (#P6001), PolyPIPosomes (#YP000; #YP003; #YP004; #YP005; #YP034; #YP035; #YP045; #YP039), and purified synthetic phosphoinositides were from Echelon Biosciences.

    Techniques: Binding Assay, Purification, Sequencing, Immunoprecipitation, Western Blot, Generated, Transfection, Mutagenesis, Isolation, Expressing, Synthesized